BreachRx key facts
as of Oct 2026- Developer of an intelligent incident response platform designed to provide operational resilience for the entire enterprise.
- BreachRx is valued at approximately $52.0M as of Oct 2026 (last reported valuation).
- It has raised $23.9M; the latest was Later Stage VC ($15.0M) in May 2025.
- Notable investors include Plug and Play Tech Center, Alchemist Accelerator, Overline, SYN Ventures, Ballistic Ventures (California) — 10 tracked in total.
- Status: Privately Held (backing).
BreachRx's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch BreachRx: the Monday email on marks, rounds and moves
BreachRx funding rounds
No funding rounds for BreachRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BreachRx valuation
BreachRx's last reported valuation was $52 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
BreachRx investors
10 investors are on record for BreachRx, including Plug and Play Tech Center, Alchemist Accelerator, Overline and SYN Ventures.
About BreachRx
Developer of an intelligent incident response platform designed to provide operational resilience for the entire enterprise. The company's platform offers automatically generated incident response plans, targeted stakeholder guidance, integrated privileged communication channels, and audit trails, enabling enterprises to maintain compliance and protect leadership from personal liability.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 35
- Website
- breachrx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.